Literature DB >> 8666529

Headache in patients with neurofibromatosis type 1.

M Clementi1, P A Battistella, L Rizzi, S Boni, R Tenconi.   

Abstract

A study of headache in a homogeneously ascertained population of 181 subjects suffering from neurofibromatosis type 1 is described. All subjects underwent a diagnostic protocol including imaging studies (for subjects over 5 years old up until 1992). Headache data were collected by means of a questionnaire. Headache was present in 55 of 181 subjects (25 males). Overall headache frequency was 30%, which is not significantly different from the frequency of headache reported in the general population. Headache was primary in 52 cases (5 migraine and 47 tension-type) and secondary to obstructive hydrocephalus with brain tumor-induced intracranial hypertension in 3 with a tension-type pattern. It was concluded that headache is not a specific feature of neurofibromatosis type 1, it is not significantly related to central nervous system abnormalities, and in itself, it is not an indication for neuroradiological examination.

Entities:  

Mesh:

Year:  1996        PMID: 8666529     DOI: 10.1046/j.1526-4610.1996.3601010.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  6 in total

1.  Occipital peripheral nerve stimulation in the management of chronic intractable occipital neuralgia in a patient with neurofibromatosis type 1: a case report.

Authors:  Ioannis Skaribas; Octavio Calvillo; Evangelia Delikanaki-Skaribas
Journal:  J Med Case Rep       Date:  2011-05-10

2.  Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.

Authors:  Alanna M Kongkriangkai; Christopher King; Lisa J Martin; Emily Wakefield; Carlos E Prada; Geraldine Kelly-Mancuso; Elizabeth K Schorry
Journal:  Am J Med Genet A       Date:  2019-02-08       Impact factor: 2.802

3.  Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.

Authors:  Marco Carotenuto; Maria Esposito
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

4.  Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1.

Authors:  Molly M Garwood; Jessica M Bernacki; Kathi M Fine; Keri R Hainsworth; W Hobart Davies; Bonita P Klein-Tasman
Journal:  Pain Res Treat       Date:  2012-09-26

5.  Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.

Authors:  Chinwe C Madubata; Margaret A Olsen; Dustin L Stwalley; David H Gutmann; Kimberly J Johnson
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

6.  The gene diagnosis of neurofibromatosis type I with headache as the main symptom: A case report and review of the literature.

Authors:  Ming Gao; Haokun Liu; Qiying Sun; Guang Yang
Journal:  Front Neurol       Date:  2022-08-01       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.